Versant Diagnostics Announces its Leadership Team

Industry experts join leading physician and operating executives to drive change

Oak Brook, Ill. (April 25, 2022) Versant Diagnostics, an independent physician services company, welcomes four new members to its leadership team. The new hires include Rob Albert as Chief Development Officer, John Horton as Vice President of Sales and Marketing, Alex Stefanowicz as Vice President of Human Resources and Corporate Services, and Allen Whitehead as Chief Financial Officer.

“I believe we are at the forefront of a digital transformation in pathology, and I am excited to participate in this revolution with the team of experts here at Versant Diagnostics,” said Jim Billington, chief executive officer. “The years of industry knowledge, integrity and vision that Rob, John, Alex, and Allen bring to the table has already been instrumental in the development of Versant Diagnostics’ strategy.”

Versant Diagnostics recently announced its strategy to help facilitate access, accuracy and care in the industry. Supported by more than $100 million in growth capital, the company will purchase pathology groups, while maintaining physician leadership and the integrity of each acquired practice. The company infuses large amounts of capital into practices to convert them to digital pathology.

“The result of our business strategy is better access to specialists when difficult cases arise, and enhancement of the workflow for pathologists,” added Dr. Ven Aduana, chairman, chief medical officer and co-founder. “The bench strength of our leadership team will help us achieve our goals and do it the right way,” said Brian Carr, board director and co-founder.

Versant Diagnostics Leadership Team

Rob Albert, Chief Development Officer, joins Versant Diagnostics after serving as Vice President and General Manager of the Northwest Region, for Labcorp. He has extensive experience in previous roles as Vice President and Chief Operating Officer in acquisition and efficiency creation for Pathology, Inc., Accumen, and Inform Diagnostics.

John Horton, Vice President of Sales and Marketing, joins the company after nearly 8 years as the Senior Area Director for the western region of the U.S. for Progenity, Inc. He has also held sales leadership roles at QIAGEN and Baylor Genetics and began his career in the lab industry with AmeriPath.

Alex Stefanowicz, Vice President of Human Resources and Corporate Services, previously led human resources and compliance for TREND Healthcare. Prior, he was Co-Founder and Vice President of Operations and Human Resources at Integrated Lab Solutions, Vice President of Human Resources at USMD Health System, and Human Resources Director at AmeriPath.

Allen Whitehead, CPA, Chief Financial Officer, spent 8 years as the Director of Finance & Controller at ProPath. Additionally, he held Senior Financial Analyst positions across additional organizations and built platforms to improve effectiveness in workflow to maximize revenue potential.


About Versant Diagnostics

Founded in 2021 by a leading physician and operating executives Ven Aduana, M.D., Jim Billington and Brian Carr, Versant Diagnostics is focused on anatomic pathology, precision medicine and the digital transformation of the industry. By combining technological advancements in healthcare with the most skilled and diverse set of subspecialty pathologists, Versant Diagnostics provides superior service for hospitals and physician practices. Learn more at